Neuralstem Company Profile (NASDAQ:CUR)

About Neuralstem

Neuralstem logoNeuralstem, Inc. (Neuralstem) is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. The Company has approximately three assets: its NSI-189 small molecule program, its NSI-566 stem cell therapy program and its chemical entity screening platform. The Company's technology allows the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the treatment of central nervous system diseases and conditions. The Company is developing NSI-189 for the treatment of major depressive disorder (MDD) and other psychiatric and/or cognitive impairment indications associated with hippocampal atrophy. The Company's NSI-566 is indicated for amyotrophic lateral sclerosis (ALS), chronic spinal cord injury and motor deficits due to ischemic stroke.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CUR
  • CUSIP:
Key Metrics:
  • Previous Close: $3.86
  • 50 Day Moving Average: $3.49
  • 200 Day Moving Average: $1.07
  • 52-Week Range: $8,835,000.00 - $0.19
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.65
  • P/E Growth: 0.00
  • Market Cap: $34.10M
  • Outstanding Shares: 8,835,000
  • Beta: 1.63
Profitability:
  • Net Margins: -170,366.66%
  • Return on Equity: -4,420.33%
  • Return on Assets: -174.10%
Debt:
  • Current Ratio: 0.85%
  • Quick Ratio: 0.85%
Additional Links:
Companies Related to Neuralstem:

Analyst Ratings

Consensus Ratings for Neuralstem (NASDAQ:CUR) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.79 (27.63% downside)

Analysts' Ratings History for Neuralstem (NASDAQ:CUR)
Show:
DateFirmActionRatingPrice TargetDetails
2/16/2017S&P Equity ResearchLower Price Target$3.69 -> $3.18View Rating Details
11/10/2016Roth CapitalReiterated RatingBuy$1.20View Rating Details
11/7/2016AegisInitiated CoverageBuyView Rating Details
10/4/2016Brean CapitalInitiated CoverageBuy$4.00View Rating Details
6/30/2015MLV & Co.Initiated CoverageBuyView Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for Neuralstem (NASDAQ:CUR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/13/2017        
11/8/2016Q3($0.03)($0.05)ViewN/AView Earnings Details
5/9/2016Q1($0.06)($0.07)ViewN/AView Earnings Details
3/14/2016Q4($0.07)($0.05)ViewN/AView Earnings Details
11/9/2015Q315($0.07)($0.06)ViewN/AView Earnings Details
8/10/2015Q2($0.06)($0.06)ViewN/AView Earnings Details
5/8/2015Q115($0.06)($0.06)$2.92 millionViewN/AView Earnings Details
4/20/2015($0.07)($0.06)ViewN/AView Earnings Details
3/16/2015($0.05)($0.06)ViewN/AView Earnings Details
11/7/2014Q314($0.05)($0.05)ViewN/AView Earnings Details
8/8/2014Q214($0.05)($0.08)ViewN/AView Earnings Details
5/12/2014Q114($0.06)($0.07)$0.35 million$0.00 millionViewN/AView Earnings Details
3/10/2014($0.06)($0.04)ViewN/AView Earnings Details
11/11/2013Q3($0.04)($0.09)ViewN/AView Earnings Details
8/9/2013Q213($0.05)($0.09)$0.08 million$0.00 millionViewN/AView Earnings Details
11/9/2012Q312($0.04)($0.04)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Neuralstem (NASDAQ:CUR)
Current Year EPS Consensus Estimate: $-2.47 EPS
Next Year EPS Consensus Estimate: $-2.34 EPS

Dividends

Dividend History for Neuralstem (NASDAQ:CUR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neuralstem (NASDAQ:CUR)
Insider Ownership Percentage: 19.25%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/25/2017Richard J DalyCEOBuy2,841$3.52$10,000.32View SEC Filing  
12/23/2016Richard J DalyCEOBuy32,259$0.31$10,000.29View SEC Filing  
11/25/2016Richard J DalyCEOBuy35,715$0.28$10,000.20View SEC Filing  
10/25/2016Richard J DalyCEOBuy35,715$0.28$10,000.20View SEC Filing  
9/23/2016Richard J DalyCEOBuy31,250$0.32$10,000.00View SEC Filing  
11/16/2015Karl JoheInsiderSell25,000$1.09$27,250.00View SEC Filing  
11/9/2015Karl JoheInsiderSell25,000$1.18$29,500.00View SEC Filing  
11/2/2015Karl JoheInsiderSell25,000$1.17$29,250.00View SEC Filing  
10/26/2015Karl JoheInsiderSell25,000$1.13$28,250.00View SEC Filing  
10/19/2015Karl JoheInsiderSell25,000$1.23$30,750.00View SEC Filing  
10/12/2015Karl JoheInsiderSell25,000$1.31$32,750.00View SEC Filing  
10/5/2015Karl JoheInsiderSell25,000$1.26$31,500.00View SEC Filing  
9/28/2015Karl JoheInsiderSell25,000$1.64$41,000.00View SEC Filing  
9/21/2015Karl JoheInsiderSell25,000$1.52$38,000.00View SEC Filing  
9/2/2014Karl JoheInsiderSell6,000$4.09$24,540.00View SEC Filing  
8/1/2014Karl JoheInsiderSell6,000$2.78$16,680.00View SEC Filing  
7/1/2014Karl JoheInsiderSell6,000$4.17$25,020.00View SEC Filing  
6/2/2014Karl JoheInsiderSell6,000$4.25$25,500.00View SEC Filing  
5/5/2014William Clyde OldakerDirectorBuy15,235$3.50$53,322.50View SEC Filing  
4/22/2014Richard GarrCEOSell7,000$4.25$29,750.00View SEC Filing  
4/1/2014Karl JoheInsiderSell6,000$4.11$24,660.00View SEC Filing  
3/20/2014Karl JoheInsiderSell6,000$4.04$24,240.00View SEC Filing  
10/18/2013Karl JoheInsiderSell10,000$2.44$24,400.00View SEC Filing  
9/20/2013Karl JoheInsiderSell10,000$2.62$26,200.00View SEC Filing  
9/19/2013Karl JoheInsiderSell10,000$2.61$26,100.00View SEC Filing  
8/20/2013Karl JoheInsiderSell20,000$1.55$31,000.00View SEC Filing  
7/22/2013Karl JoheInsiderSell12,800$1.62$20,736.00View SEC Filing  
6/20/2013Karl JoheInsiderSell12,800$1.40$17,920.00View SEC Filing  
6/7/2013Richard GarrCEOSell6,000$1.42$8,520.00View SEC Filing  
5/20/2013Karl JoheInsiderSell12,800$1.51$19,328.00View SEC Filing  
2/25/2013Richard GarrCEOSell12,000$1.15$13,800.00View SEC Filing  
11/20/2012Karl JoheInsiderSell12,800$1.00$12,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Neuralstem (NASDAQ:CUR)
DateHeadline
News IconMurry Sells 5971 Shares of US Silica Holdings, Inc. (SLCA) Stock (NASDAQ:CUR)
ekosvoice.com - February 24 at 10:04 PM
News IconInvesting Focus: Indicators in View on Shares of Neuralstem Inc (CUR) - Davidson Register (NASDAQ:CUR)
davidsonregister.com - February 24 at 12:04 PM
News IconShare Watch: Examining the Levels for Neuralstem, Inc. (NASDAQ:CUR) - Baldwin Journal (NASDAQ:CUR)
baldwinjournal.com - February 24 at 12:04 PM
News IconNeuralstem Inc CUR Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:CUR)
www.bioportfolio.com - February 22 at 4:49 PM
us.rd.yahoo.com logoNeuralstem Announces Issuance of U.S. Patent Covering NSI-189 (NASDAQ:CUR)
us.rd.yahoo.com - February 22 at 4:49 PM
us.rd.yahoo.com logo7:04 am Neuralstem confirms that U.S. Patent No. 9572807 was issued by the United States Patent and Trademark Office for NSI-189 the lead compound in Neuralstem's neurogenic small molecule program in development for the treatment of major d (NASDAQ:CUR)
us.rd.yahoo.com - February 22 at 4:49 PM
News IconMA Watch on Shares of Neuralstem Inc (CUR) - Davidson Register (NASDAQ:CUR)
davidsonregister.com - February 22 at 9:25 AM
News IconMarket Scope: Viewing Shares of Neuralstem, Inc. (NASDAQ:CUR) - Midway Monitor (NASDAQ:CUR)
midwaymonitor.com - February 22 at 9:25 AM
streetinsider.com logoNeuralstem (CUR) Confirms US Patent Covering NSI-189 - StreetInsider.com (NASDAQ:CUR)
www.streetinsider.com - February 22 at 9:25 AM
News IconFirst Heartland Consultants Inc. Cuts Position in Enterprise Products Partners LP (EPD) (NASDAQ:CUR)
ekosvoice.com - February 18 at 9:28 AM
News IconEye on Technicals Neuralstem Inc. (CUR) - Benton Bulletin (NASDAQ:CUR)
bentonbulletin.com - February 17 at 3:38 PM
News IconNeuralstem, Inc. NASDAQ:CUR Experiences Unusual Volatility Mid-Market - Aiken Advocate (NASDAQ:CUR)
aikenadvocate.com - February 17 at 3:38 PM
News IconA Keen Look At The Chart For Neuralstem, Inc. (CUR) - NY Stock News (NASDAQ:CUR)
nystocknews.com - February 17 at 3:38 PM
News IconNeuralstem, Inc. (NASDAQ:CUR) Breaks Higher as Phase 2 Comes Together - The Oracle Dispatch (NASDAQ:CUR)
oracledispatch.com - February 17 at 3:38 PM
News IconNeuralstem, Inc. (CUR) Is Up. Here’s Why And What It Means (NASDAQ:CUR)
feedproxy.google.com - February 17 at 1:28 PM
News IconEarnings And Analyst Opinion Offer Spending Insights: Neuralstem, Inc. (CUR), GigPeak, Inc. (GIG) - Post Analyst (NASDAQ:CUR)
postanalyst.com - February 17 at 8:13 AM
marketexclusive.com logoNeuralstem, Inc. (NASDAQ:CUR) Is Up. Here's Why And What It Means - Market Exclusive (NASDAQ:CUR)
marketexclusive.com - February 17 at 8:13 AM
streetinsider.com logoUPDATE: Neuralstem (CUR) Halted on LUDP After Announcing Phase 2 NSI-189 Data Now Expected Ahead of Schedule (NASDAQ:CUR)
www.streetinsider.com - February 16 at 6:39 PM
streetinsider.com logoUPDATE: Neuralstem (CUR) Halted on LUDP After Announcing Phase 2 NSI-189 Data Now Expected Ahead of Schedule (NASDAQ:CUR)
www.streetinsider.com - February 16 at 6:39 PM
biz.yahoo.com logoNEURALSTEM, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:CUR)
biz.yahoo.com - February 16 at 6:39 PM
feeds.benzinga.com logo18 Biggest Mid-Day Gainers For Thursday (NASDAQ:CUR)
feeds.benzinga.com - February 16 at 1:42 PM
News IconNeuralstem, Inc. (CUR) Under Analyst Spotlight - UK Market News (NASDAQ:CUR)
www.ukmarketnews.co.uk - February 16 at 1:38 PM
benzinga.com logo18 Biggest Mid-Day Gainers For Thursday - Benzinga (NASDAQ:CUR)
www.benzinga.com - February 16 at 1:38 PM
streetinsider.com logoUPDATE: Neuralstem (CUR) Halted on LUDP After Announcing Phase 2 NSI-189 Data Now Expected Ahead of ... - StreetInsider.com (NASDAQ:CUR)
www.streetinsider.com - February 16 at 1:38 PM
finance.yahoo.com logoNeuralstem Announces Last Subject Enrolled in Phase 2 Trial with NSI-189 for Major Depressive Disorder (NASDAQ:CUR)
finance.yahoo.com - February 16 at 1:38 PM
globenewswire.com logoNeuralstem to Present at BIO CEO & Investor Conference - GlobeNewswire (press release) (NASDAQ:CUR)
globenewswire.com - February 14 at 3:47 PM
finance.yahoo.com logoNeuralstem to Present at BIO CEO & Investor Conference (NASDAQ:CUR)
finance.yahoo.com - February 13 at 5:16 PM
News IconStock Checkup: Technical Watch on Neuralstem Inc. (CUR) - Rives Journal (NASDAQ:CUR)
rivesjournal.com - February 11 at 2:58 AM
News IconInvestor Corner: Checking the Charts for Neuralstem Inc. (CUR) - Sherwood Daily (NASDAQ:CUR)
sherwooddaily.com - February 11 at 2:58 AM
News IconEquity Rundown: RSI and CCI Check on Neuralstem Inc. (CUR) - Sherwood Daily (NASDAQ:CUR)
sherwooddaily.com - February 4 at 2:54 AM
News IconTechnical Watch on These Shares: Neuralstem Inc. (CUR) - Sherwood Daily (NASDAQ:CUR)
sherwooddaily.com - February 1 at 3:16 AM
News IconInvestors Swarm in on Neuralstem, Inc. (NASDAQ:CUR) - Prospect Journal (NASDAQ:CUR)
prospectjournal.com - February 1 at 3:16 AM
News IconNeuralstem, Inc. (CUR) Updated Broker Ratings - NewsDen - NewsDen (NASDAQ:CUR)
newsden.net - January 30 at 5:28 PM
News IconStock Tracker: Earnings & Estimates for Neuralstem, Inc. (NASDAQ:CUR) - Aiken Advocate (NASDAQ:CUR)
aikenadvocate.com - January 30 at 5:28 PM
News IconHigh Volatility Moving the Needle For Shares of Neuralstem, Inc. (NASDAQ:CUR) - Wall Street Beacon (NASDAQ:CUR)
wsbeacon.com - January 30 at 5:28 PM
insidermonkey.com logoFounder of Largest U.S. Homebuilder Sells Shares Amid Signs of Housing Recovery & Other Noteworthy Insider Trading (NASDAQ:CUR)
www.insidermonkey.com - January 30 at 9:30 AM
News IconInvestor Technical Review for Neuralstem Inc. (CUR) - Rives Journal (NASDAQ:CUR)
rivesjournal.com - January 28 at 4:48 PM
News IconInvestor Corner: Checking in on Shares of Neuralstem Inc. (CUR) - Sherwood Daily (NASDAQ:CUR)
sherwooddaily.com - January 26 at 5:44 PM
News IconEarnings Analysis & Update for Neuralstem, Inc. (NASDAQ:CUR)? - Aiken Advocate (NASDAQ:CUR)
aikenadvocate.com - January 24 at 10:09 PM
News IconEarnings in Full Force, Analysts Take Aim at Neuralstem, Inc. (NASDAQ:CUR) - Wall Street Beacon (NASDAQ:CUR)
wsbeacon.com - January 24 at 10:09 PM
capitalcube.com logoETFs with exposure to Neuralstem, Inc. : January 19, 2017 (NASDAQ:CUR)
www.capitalcube.com - January 19 at 5:52 PM
News IconWhat are the Levels Showing for Shares of Neuralstem Inc. (CUR) - Rives Journal (NASDAQ:CUR)
rivesjournal.com - January 19 at 2:59 AM
seekingalpha.com logoNeuralstem completes round trip - Seeking Alpha (NASDAQ:CUR)
seekingalpha.com - January 19 at 2:59 AM
News IconNeuralstem Inc CUR Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:CUR)
www.bioportfolio.com - January 18 at 3:29 AM
News IconInvestors Priming the Pump as Stock Reaches Most Volatile List: Neuralstem, Inc. (NASDAQ:CUR) - Wall Street Beacon (NASDAQ:CUR)
wsbeacon.com - January 17 at 10:28 PM
News IconStock Momentum Skidding to a Halt For Neuralstem, Inc. (NASDAQ:CUR) - Wall Street Beacon (NASDAQ:CUR)
wsbeacon.com - January 17 at 10:28 PM
News IconWhat is the Sell-side Saying About Neuralstem, Inc. (NASDAQ:CUR)? - Aiken Advocate (NASDAQ:CUR)
aikenadvocate.com - January 17 at 8:35 AM
News IconWill The Needle Move For Neuralstem, Inc. (NASDAQ:CUR) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:CUR)
wsbeacon.com - January 17 at 8:35 AM
News IconNeuralstem, Inc. CUR Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:CUR)
www.bioportfolio.com - January 15 at 4:28 PM
News IconShares Backsliding in Session: Neuralstem, Inc. (NASDAQ:CUR) - Wall Street Beacon (NASDAQ:CUR)
wsbeacon.com - January 13 at 3:03 AM

Social

What is Neuralstem's stock symbol?

Neuralstem trades on the NASDAQ under the ticker symbol "CUR."

Where is Neuralstem's stock going? Where will Neuralstem's stock price be in 2017?

3 brokers have issued 1 year price objectives for Neuralstem's shares. Their forecasts range from $1.20 to $4.00. On average, they anticipate Neuralstem's stock price to reach $2.79 in the next twelve months.

When will Neuralstem announce their earnings?

Neuralstem is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.

How do I buy Neuralstem stock?

Shares of Neuralstem can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Neuralstem stock cost?

One share of Neuralstem stock can currently be purchased for approximately $3.86.

Neuralstem (NASDAQ:CUR) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Neuralstem (NASDAQ:CUR)

Earnings History Chart

Earnings by Quarter for Neuralstem (NASDAQ:CUR)

Dividend History Chart

Dividend Payments by Quarter for Neuralstem (NASDAQ:CUR)

Last Updated on 2/26/2017 by MarketBeat.com Staff